DRUGS MADE IN AMERICA ACQUIS
DMAAU · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $10.99
- Today’s Low
- $10.99
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $10.99
- Previous Close
- $10.99
- Volume
- 2
- Market Cap
- $263.64M
- P/E Ratio
- 43.25X
- EPS
- $0.20
Previous Day Range
52-Week Range
Company Overview
- Sector
- FINANCIAL SERVICES
- Industry
- N/A
- Sub-industry
- SHELL COMPANIES
- Headquarters
- 420 LEXINGTON AVENUE, NEW YORK, NY, UNITED STATES, 10170
- Country
- US
- Listing Date
- 2025-01-28
- Fiscal Year End
- December
- Shares Outstanding
- 24.28M
- CIK
- --
- Website
- dmaacorp.com
Drugs Made In America Acquisition Corp. Units (DMAAU) is a special purpose acquisition company (SPAC) focused on merging with innovative firms within the pharmaceutical and healthcare sectors. Leveraging a seasoned management team with deep industry experience, DMAAU aims to address the increasing demand for domestic drug production amid rising concerns over healthcare affordability and accessibility in the U.S. This strategic approach positions DMAAU as an attractive opportunity for institutional investors looking to engage with transformative healthcare solutions that can shape the future of the industry.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$136.93K
2026-03-31
$143.3K
2025-12-31
$2.08M
2025-09-30
$263.7K
Net Income
2026-06-30
$1.72M
2026-03-31
$1.97M
2025-12-31
$212.95K
2025-09-30
$2.18M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$0.05
2026-03-31
$0.05
2025-12-31
$0.00
2025-09-30
$0.07
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$136.93K
2026-03-31
-$143.3K
2025-12-31
-$2.08M
2025-09-30
-$263.7K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $136.93K | $143.3K | $2.08M | $263.7K |
| Net Income | $1.72M | $1.97M | $212.95K | $2.18M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $0.05 | $0.05 | $0.00 | $0.07 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$136.93K | -$143.3K | -$2.08M | -$263.7K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.